市場調查報告書
商品編碼
1087250

前列腺癌治療藥的全球市場:產業分析,趨勢,市場規模,預測(∼2028年)

Prostate Cancer Therapeutics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2028

出版日期: | 出版商: Infinium Global Research (IGR) | 英文 100 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球前列腺癌治療藥的市場規模在2022∼2028年的預測期間中預計將以8.5%的年複合成長率成長。

本報告提供全球前列腺癌治療藥市場相關調查分析,提供市場促進因素,阻礙因素,市場機會,宏觀指標分析,零組件·流通管道·各地區市場分析,企業簡介等相關資訊。

目錄

第1章 序文

  • 報告的說明
  • 調查方法
  • 研究途徑

第2章 摘要整理

  • 前列腺癌治療藥市場概況
  • 前列腺癌治療藥市場預測
  • 前列腺癌治療藥市場地區的亮點

第3章 全球前列腺癌治療藥:市場概要

  • 簡介
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • 前列腺癌治療藥市場的COVID-19影響分析
  • 波特的五力分析
  • IGR-成長矩陣分析
    • IGR-成長矩陣分析:各零件
    • IGR-成長矩陣分析:各流通管道
    • IGR-成長矩陣分析:各地區
  • 前列腺癌治療藥市場價值鏈分析

第4章 前列腺癌治療藥市場宏觀指標分析

第5章 全球前列腺癌治療藥市場:各零件

  • 荷爾蒙療法
    • LHRH(黃體激素放出荷爾蒙)拮抗劑
    • LHRH(黃體激素放出荷爾蒙)激動劑
    • 抗雄激素劑
  • 化療
  • 免疫療法
  • 放射治療

第6章 全球前列腺癌治療藥市場:各流通管道

  • 醫院藥局
  • 零售藥局
  • 銷售·糖尿病相關

第7章 全球前列腺癌治療藥市場:各地區(2022∼2028年)

  • 北美
    • 各零件
    • 各流通管道
    • 各國
  • 歐洲
    • 各零件
    • 各流通管道
    • 各國
  • 亞太地區
    • 各零件
    • 各流通管道
    • 各國
  • 其他地區
    • 各零件
    • 各流通管道
    • 各子地區

第8章 企業簡介和競爭情形

  • 競爭情形
  • 企業簡介
    • Pfizer Inc.
    • Abbott Laboratories
    • AstraZeneca plc
    • Astellas Pharma Inc.
    • Bristol-Myers Squibb
    • Johnson & Johnson
    • Sanofi
    • AbbVie, Inc.
    • Teva Pharmaceuticals
    • Takeda Pharmaceuticals
目錄
Product Code: HC0094

The report on the global prostate cancer therapeutics market provides qualitative and quantitative analysis for the period from 2020 to 2028. The report predicts the global prostate cancer therapeutics market to grow with a CAGR of 8.5% over the forecast period from 2022-2028. The study on prostate cancer therapeutics market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2020 to 2028.

The report on prostate cancer therapeutics market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global prostate cancer therapeutics market over the period of 2020 to 2028. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global prostate cancer therapeutics market over the period of 2020 to 2028. Further, IGR- Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers

  • Prevalence of prostate cancer
  • Innovations in the development of new drugs and therapies of cancer

2) Restraints

  • High cost of prostate cancer drugs

3) Opportunities

  • Rising investment in R&D of new drugs

Research Methodology

A) Primary Research

Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include

  • 1. Key Opinion Leaders associated with Infinium Global Research
  • 2. Internal and External subject matter experts
  • 3. Professionals and participants from the industry

Our primary research respondents typically include

  • 1. Executives working with leading companies in the market under review
  • 2. Product/brand/marketing managers
  • 3. CXO level executives
  • 4. Regional/zonal/ country managers
  • 5. Vice President level executives.

B) Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include

  • 1. Company reports and publications
  • 2. Government/institutional publications
  • 3. Trade and associations journals
  • 4. Databases such as WTO, OECD, World Bank, and among others.
  • 5. Websites and publications by research agencies

Segment Covered

The global prostate cancer therapeutics market is segmented on the basis of component, and distribution channel.

The Global Prostate Cancer Therapeutics Market by Component

  • Hormonal Therapy

LHRH (Luteinizing Hormone Releasing Hormone) Antagonists

LHRH (Luteinizing Hormone Releasing Hormone) Agonists

Anti-androgen

  • Chemotherapy
  • Immunotherapy
  • Radiation Therapy

The Global Prostate Cancer Therapeutics Market by Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Sales and Diabetes

Company Profiles

The companies covered in the report include

  • Pfizer Inc.
  • Abbott Laboratories
  • AstraZeneca plc
  • Astellas Pharma Inc.
  • Bristol-Myers Squibb
  • Johnson & Johnson
  • Sanofi
  • AbbVie, Inc.
  • Teva Pharmaceuticals
  • Takeda Pharmaceuticals

What does this Report Deliver?

1. Comprehensive analysis of the global as well as regional markets of the prostate cancer therapeutics market.

2. Complete coverage of all the segments in the prostate cancer therapeutics market to analyze the trends, developments in the global market and forecast of market size up to 2028.

3. Comprehensive analysis of the companies operating in the global prostate cancer therapeutics market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.

4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Table of Contents

1. Preface

  • 1.1. Report Description
  • 1.2. Research Methods
  • 1.3. Research Approaches

2. Executive Summary

  • 2.1. Prostate Cancer Therapeutics Market Highlights
  • 2.2. Prostate Cancer Therapeutics Market Projection
  • 2.3. Prostate Cancer Therapeutics Market Regional Highlights

3. Global Prostate Cancer Therapeutics Market Overview

  • 3.1. Introduction
  • 3.2. Market Dynamics
    • 3.2.1. Drivers
    • 3.2.2. Restraints
    • 3.2.3. Opportunities
  • 3.3. Analysis of COVID-19 impact on the Prostate Cancer Therapeutics Market
  • 3.4. Porter's Five Forces Analysis
  • 3.5. IGR-Growth Matrix Analysis
    • 3.5.1. IGR-Growth Matrix Analysis by Component
    • 3.5.2. IGR-Growth Matrix Analysis by Distribution Channel
    • 3.5.3. IGR-Growth Matrix Analysis by Region
  • 3.6. Value Chain Analysis of Prostate Cancer Therapeutics Market

4. Prostate Cancer Therapeutics Market Macro Indicator Analysis

5. Global Prostate Cancer Therapeutics Market by Component

  • 5.1. Hormonal Therapy
    • 5.1.1. LHRH (Luteinizing Hormone Releasing Hormone) Antagonists
    • 5.1.2. LHRH (Luteinizing Hormone Releasing Hormone) Agonists
    • 5.1.3. Anti-androgen
  • 5.2. Chemotherapy
  • 5.3. Immunotherapy
  • 5.4. Radiation Therapy

6. Global Prostate Cancer Therapeutics Market by Distribution Channel

  • 6.1. Hospital Pharmacy
  • 6.2. Retail Pharmacy
  • 6.3. Sales and Diabetes

7. Global Prostate Cancer Therapeutics Market by Region 2022-2028

  • 7.1. North America
    • 7.1.1. North America Prostate Cancer Therapeutics Market by Component
    • 7.1.2. North America Prostate Cancer Therapeutics Market by Distribution Channel
    • 7.1.3. North America Prostate Cancer Therapeutics Market by Country
  • 7.2. Europe
    • 7.2.1. Europe Prostate Cancer Therapeutics Market by Component
    • 7.2.2. Europe Prostate Cancer Therapeutics Market by Distribution Channel
    • 7.2.3. Europe Prostate Cancer Therapeutics Market by Country
  • 7.3. Asia-Pacific
    • 7.3.1. Asia-Pacific Prostate Cancer Therapeutics Market by Component
    • 7.3.2. Asia-Pacific Prostate Cancer Therapeutics Market by Distribution Channel
    • 7.3.3. Asia-Pacific Prostate Cancer Therapeutics Market by Country
  • 7.4. RoW
    • 7.4.1. RoW Prostate Cancer Therapeutics Market by Component
    • 7.4.2. RoW Prostate Cancer Therapeutics Market by Distribution Channel
    • 7.4.3. RoW Prostate Cancer Therapeutics Market by Sub-region

8. Company Profiles and Competitive Landscape

  • 8.1. Competitive Landscape in the Global Prostate Cancer Therapeutics Market
  • 8.2. Companies Profiles
    • 8.2.1. Pfizer Inc.
    • 8.2.2. Abbott Laboratories
    • 8.2.3. AstraZeneca plc
    • 8.2.4. Astellas Pharma Inc.
    • 8.2.5. Bristol-Myers Squibb
    • 8.2.6. Johnson & Johnson
    • 8.2.7. Sanofi
    • 8.2.8. AbbVie, Inc.
    • 8.2.9. Teva Pharmaceuticals
    • 8.2.10. Takeda Pharmaceuticals